NYSE:BAX - Baxter International Stock Price, Forecast & News

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, November 19th. Investors of record on Friday, December 6th will be given a dividend of $0.22 per share on Thursday, January 2nd. This represents a $0.88 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend is Thursday, December 5th. View Baxter International's Dividend History.

Baxter International announced that its Board of Directors has approved a stock buyback plan on Tuesday, November 13th 2018, which allows the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 6.1% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's board believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) released its earnings results on Wednesday, October, 31st. The medical instruments supplier reported $0.80 EPS for the quarter, beating analysts' consensus estimates of $0.74 by $0.06. The medical instruments supplier had revenue of $2.77 billion for the quarter, compared to analysts' expectations of $2.79 billion. Baxter International had a return on equity of 22.99% and a net margin of 13.80%. The business's revenue was up 2.2% on a year-over-year basis. During the same quarter last year, the business posted $0.64 EPS. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, January 30th 2020. View Earnings Estimates for Baxter International.

15 brokers have issued 12 month price targets for Baxter International's shares. Their forecasts range from $75.00 to $109.00. On average, they expect Baxter International's share price to reach $93.15 in the next twelve months. This suggests a possible upside of 3.8% from the stock's current price. View Analyst Price Targets for Baxter International.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Media coverage about BAX stock has been trending positive recently, InfoTrie reports. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Baxter International earned a daily sentiment score of 3.0 on InfoTrie's scale. They also assigned news coverage about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Baxter International.

Baxter International saw a drop in short interest during the month of December. As of December 13th, there was short interest totalling 4,300,000 shares, a drop of 18.4% from the November 28th total of 5,270,000 shares. Based on an average trading volume of 2,860,000 shares, the short-interest ratio is presently 1.5 days. Currently, 0.8% of the shares of the company are short sold. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR), Steris (STE) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Cisco Systems (CSCO), BlackRock (BLK), Johnson & Johnson (JNJ), Verizon Communications (VZ), Honeywell International (HON), Home Depot (HD), Alibaba Group (BABA), Procter & Gamble (PG) and Endologix (ELGX).

Baxter International's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Calamos Advisors LLC (0.19%), Huntington National Bank (0.10%), PGGM Investments (0.09%), Gateway Investment Advisers LLC (0.06%), Nisa Investment Advisors LLC (0.05%) and State of Alaska Department of Revenue (0.03%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Bangor Savings Bank, United Services Automobile Association, Gateway Investment Advisers LLC, Calamos Advisors LLC, First Hawaiian Bank, Tocqueville Asset Management L.P., Dalton Greiner Hartman Maher & Co. and CenturyLink Investment Management Co. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was purchased by a variety of institutional investors in the last quarter, including PGGM Investments, Nisa Investment Advisors LLC, FormulaFolio Investments LLC, Huntington National Bank, DNB Asset Management AS, Larson Financial Group LLC, Baxter Bros Inc. and Baxter Bros Inc.. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $89.73.

Baxter International has a market capitalization of $45.81 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

The official website for Baxter International is http://www.baxter.com/.

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]